Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Manufacturers—Specialty & Generic Average | - - | - - | - - | 550,301.27 | 30,726.14 | 1,469.31 | 109,782.24 | -706.69 | 0.13 | 13.2010 | 37.11 | 31.0967 | -130.7461 | 0.12 | 4.08 | 198.0875 | - - | ||
Maximum | - - | - - | - - | 9,731,303.00 | 444,593.00 | 12,710.00 | 1,955,691.00 | 6,978.00 | 1.00 | 129.5393 | 319.88 | 97.5200 | 69.5400 | 7.56 | 145.73 | 1,374.4000 | - - | ||
Minimum | - - | - - | - - | 0.00 | 0.00 | -101.00 | -13,707.00 | -17,092.00 | 0.00 | -183.3601 | -0.63 | -392.5400 | -4,237.3100 | -30.79 | -89.90 | 0.0000 | - - | ||
Elanco Animal Health Incorporated ELAN | 14.12 | -0.53 -3.61% | 1,471 vs. 5,342 | 6,979.00 | 1,205.00 | 32.00 | -22.00 | -2,256.00 | 0.0600 | 61.5344 | 0.00 | 57.26 | 2.66 | 0.53 | 0.23 | 115.50 | 494.00 | ||
Amphastar Pharmaceuticals, Inc. AMPH | 50.11 | 0.33 0.66% | 25 vs. 392 | 2,439.00 | 171.00 | 43.00 | 46.00 | 452.00 | 0.9000 | 12.1264 | 0.00 | 50.80 | 25.13 | 6.42 | 2.74 | 168.56 | 48.00 | ||
Perrigo Company plc PRGO | 28.08 | -0.08 -0.28% | 64 vs. 1,349 | 3,830.00 | 1,082.00 | 4.00 | -26.00 | -2,078.00 | 0.0300 | 268.1192 | 0.86 | 33.09 | 0.38 | 0.09 | 0.04 | 94.19 | 136.00 |